Dr. Peters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1110 Meade St
Dunmore, PA 18512Phone+1 570-504-7200Fax+1 570-504-7217
Education & Training
- Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2004 - 2008
- The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 2003 - 2004
- Case Western Reserve University School of MedicineClass of 2003
- University of PennsylvaniaBA, 1993 - 1997
Certifications & Licensure
- NY State Medical License 2005 - 2026
- NJ State Medical License 2011 - 2025
- PA State Medical License 2007 - 2024
- OH State Medical License 2003 - 2004
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha (AOA) Medical Honor Society Alpha Omega Alpha
- ASTRO Apex Accreditation American Society of Radiation Oncology
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer Start of enrollment: 2009 Aug 27
Publications & Presentations
PubMed
- 44 citationsA genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapyJamie A. Cesaretti, Richard G. Stock, David P. Atencio, Sheila Peters, Christopher A. Peters
International Journal of Radiation Oncology, Biology, Physics. 2007-08-01 - 89 citationsEffect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 05...Seth A. Rosenthal, Chen Hu, Oliver Sartor, Leonard G. Gomella, Mahul B. Amin
Journal of Clinical Oncology. 2019-03-12 - 75 citationsAssociation of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for pros...Ryan J. Burri, Richard G. Stock, Jamie A. Cesaretti, David P. Atencio, Sheila Peters
Radiation Research. 2008-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: